# Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) Vaccine

> **NCT00654316** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 11 (actual)

## Conditions studied

- TB

## Interventions

- **BIOLOGICAL:** BCG

## Key facts

- **NCT ID:** NCT00654316
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2008-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00654316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00654316, "Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) Vaccine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00654316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*